Codexis, Inc.

CDXS

$1.72

Name : Codexis, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $155,357,936.00

EPSttm : -0.73

Codexis, Inc.

$1.72

5.52%

$0.09

Float Short %

6.64

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

0.11

EPS Last/This Y

0.29

EPS This/Next Y

0.11

Price

1.72

Target Price

6.58

Analyst Recom

1.57

Performance Q

-36.06

Relative Volume

0.55

Beta

2.47

Ticker: CDXS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-08	CDXS	1.925	0.06	1.25	2730
2025-12-09	CDXS	1.86	0.06	0.00	2733
2025-12-10	CDXS	1.815	0.06	0.02	2753
2025-12-11	CDXS	1.705	0.06	0.00	2814
2025-12-12	CDXS	1.675	0.06	0.00	2814
2025-12-15	CDXS	1.63	0.06	0.00	2814
2025-12-16	CDXS	1.675	0.05	0.00	2791
2025-12-17	CDXS	1.6	0.05	0.00	2791
2025-12-18	CDXS	1.63	0.05	0.00	2881
2025-12-19	CDXS	1.67	0.05	0.00	2881
2025-12-22	CDXS	1.7	0.06	0.00	1713
2025-12-23	CDXS	1.655	0.06	999.99	1711
2025-12-26	CDXS	1.625	0.06	0.50	1711
2025-12-29	CDXS	1.65	0.06	0.14	1713
2025-12-30	CDXS	1.6	0.06	0.00	1721
2025-12-31	CDXS	1.62	0.06	0.00	1726
2026-01-02	CDXS	1.625	0.06	0.00	1732
2026-01-05	CDXS	1.635	0.06	0.00	1734
2026-01-06	CDXS	1.715	0.06	0.00	1745
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-08	CDXS	1.92	73.1	-	-0.60
2025-12-09	CDXS	1.87	73.1	-	-0.60
2025-12-10	CDXS	1.87	73.1	-	-0.60
2025-12-11	CDXS	1.71	73.1	-	-0.60
2025-12-12	CDXS	1.68	73.1	-	-0.60
2025-12-15	CDXS	1.63	73.1	-	-0.60
2025-12-16	CDXS	1.63	73.1	-	-0.60
2025-12-17	CDXS	1.61	73.1	-	-0.60
2025-12-18	CDXS	1.63	73.1	-	-0.60
2025-12-19	CDXS	1.66	73.1	-	-0.60
2025-12-22	CDXS	1.68	73.1	-	-0.60
2025-12-23	CDXS	1.65	73.1	-	-0.60
2025-12-26	CDXS	1.62	73.1	-	-0.60
2025-12-29	CDXS	1.65	73.1	-	-0.60
2025-12-30	CDXS	1.60	73.1	-	-0.60
2025-12-31	CDXS	1.62	73.1	-	-0.60
2026-01-02	CDXS	1.63	73.1	-	-0.60
2026-01-05	CDXS	1.63	73.1	-	-0.60
2026-01-06	CDXS	1.72	73.1	-	-0.60
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-08	CDXS	-22.51	-7.68	5.60
2025-12-09	CDXS	-22.51	-7.68	5.60
2025-12-10	CDXS	-22.51	-7.68	6.93
2025-12-11	CDXS	-22.51	-7.68	6.93
2025-12-12	CDXS	-22.51	-7.68	6.93
2025-12-15	CDXS	-22.51	-7.69	6.93
2025-12-16	CDXS	-22.51	-7.69	6.93
2025-12-17	CDXS	-27.58	-7.69	6.93
2025-12-18	CDXS	-27.59	-7.69	6.93
2025-12-19	CDXS	-27.59	-7.69	6.93
2025-12-22	CDXS	-27.58	-7.69	6.93
2025-12-23	CDXS	-27.58	-7.69	6.93
2025-12-26	CDXS	-27.59	-7.69	6.64
2025-12-29	CDXS	-27.58	-7.70	6.64
2025-12-30	CDXS	-27.58	-7.70	6.64
2025-12-31	CDXS	-27.59	-7.70	6.64
2026-01-02	CDXS	-29.43	-7.70	6.64
2026-01-05	CDXS	-29.43	-7.70	6.64
2026-01-06	CDXS	-29.43	-7.70	6.64
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.22

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.11

Insider Transactions

-29.43

Institutional Transactions

-7.7

Beta

2.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.9

Max Drawdown 5-Year %

-96.4

Target Price

6.58

P/E

Forward P/E

PEG

P/S

2.94

P/B

4.03

P/Free Cash Flow

EPS

-0.75

Average EPS Est. Cur. Y

-0.6

EPS Next Y. (Est.)

-0.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-120.82

Relative Volume

0.55

Return on Equity vs Sector %

-193

Return on Equity vs Industry %

-177.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Codexis, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 188

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

stock quote shares CDXS – Codexis, Inc. Stock Price stock today

news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CDXS – Codexis, Inc. yahoo finance google finance

stock history CDXS – Codexis, Inc. invest stock market

stock prices CDXS premarket after hours

ticker CDXS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CDXS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y